Related Experiment Video
Updated: Jan 9, 2026

10:21
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
3.6K
Artificial Intelligence Tools for Drug Target Discovery Research: Database, Tools, Applications, and Challenges.
Rui Zhang1, Shao-Xuan Liu1, Yang Tao1
1School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|December 6, 2025
Summary
Artificial intelligence (AI) accelerates drug discovery by improving drug-target interaction prediction. This review guides researchers in using AI tools and databases to overcome challenges and speed up novel drug development.
Area of Science:
- Biomedical research
- Computational biology
- Drug discovery
Background:
- Drug target identification is a major challenge in pharmaceutical research.
- Artificial intelligence (AI) offers powerful tools for predicting drug-target interactions.
- AI can analyze large biomedical datasets to understand drug mechanisms.
Purpose of the Study:
- To provide a comprehensive overview of AI applications in drug target discovery.
- To highlight the potential and challenges of AI in pharmaceutical research.
- To offer practical guidance for integrating AI into drug discovery workflows.
Main Methods:
- Review of recent public databases and computational methods.
- Analysis of AI-driven approaches for drug-target interaction prediction.
- Exploration of user-friendly AI tools for researchers.
Main Results:
- AI significantly enhances the efficiency and accuracy of virtual screening, binding affinity estimation, and target identification.
- AI enables deeper insights into complex biological networks and drug mechanisms.
- Key challenges include ensuring prediction precision and integrating AI into existing workflows.
Conclusions:
- AI holds immense potential to accelerate the discovery of novel therapeutic drugs.
- Overcoming integration barriers and ensuring prediction accuracy are crucial for widespread AI adoption.
- This review empowers researchers, even those without computational expertise, to leverage AI for drug discovery.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K

